Three-year assessment of the counselling cannabis clinics for young users (2005-2007)
Tendances n° 63, OFDT, 4 p.
Cannabis is the most widely used illegal substance in France, particularly in young people, despite a fall in use since 2002 after ten years of continuous increase. In 2007, 5% of 16-year-old males and 2% of 16-year-old females reported that they used cannabis regularly.
Three years after the introduction of the "clinics for young users" (CYU) and following an initial survey, this work reviews the change in the outpatients' profiles (see box) based on the responses of professionals who managed the outpatients in 226 of the 274 CYU identified in 2007 (or 82%). The analyses are based on a sample of 3,788 people, of whom 2,938 were substance users (77.6% of the public in a given month), 79% of whom attended alone, and 850 people from the person's family or close friends (22.4%). These allow the new trends and features of the public seen to be identified by recruitment sector. The results presented include previously unpublished findings about the nature of the requests, the reasons for use, criteria used to assess dependency, responses offered to the different user profiles and the change in their use trajectory during the sessions.
Download the PDF file (116 Ko)
Drugs in Europe
- Drug facts, figures and analyses: across Europe and by country
- Latest trends and legal, political and social responses
- Selected issues: Vulnerable groups of young people; National drug-related research in Europe; Towards a better understanding of drug-related public expenditure in Europe
Country situation summaries
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) website has a concise overview for each EU Member State on their national drug situation, as well as legal texts in their original formats, an indispensable tool for monitoring and analysing legislative developments in the Member States.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.